Pancreatic Cancer CT: Prediction of Resectability according to NCCN Criteria

Radiologic resectability assessment in pancreatic cancer.

Complete tumor resection is still the only potentially curative therapy option for patients with ductal adenocarcinoma of the pancreas. Surgical exploration is the gold standard for the determination of tumor resectability. Radiological resectability assessment is of great importance because many clearly unresectable cases can be identified preoperatively and it became essential for surgical pl...

Predicting resectability of pancreatic head cancer with multi-detector CT. Surgical and pathologic correlation.

CONTEXT Computed tomography is widely used to pre-operatively evaluate patients with ductal carcinoma of the pancreas. OBJECTIVE To prospectively evaluate the ability of multi-detector computed tomography to predict resectability of pancreatic head cancer. PATIENTS Ninety-one consecutive patients (53 men, 38 women; mean age, 61 years) referred to our department with a diagnosis of cancer of...

Predictive factors of resectability and postoperative outcome for pancreatic cancer

Pancreatic cancer still remains a challenge for surgeons. The goal of surgery is to ensure oncological R0 resection as positive resection margin is associated with poor prognosis. The purpose of this study is to determine the utility of age, ASA score, bilirubin and albumin value, CA 19-9 and imaging modalities for predicting the resectability in pancreatic cancer. This retrospective study cons...

Utility of tumor markers in determining resectability of pancreatic cancer.

HYPOTHESIS Despite advances in preoperative radiologic imaging, a significant fraction of potentially resectable pancreatic cancers are found to be unresectable at laparotomy. We tested the hypothesis that preoperative serum levels of CA19-9 (cancer antigen) and carcinoembryonic antigen will identify patients with unresectable pancreatic cancer despite radiologic staging demonstrating resectabl...

Pancreatic Adenocarcinoma NCCN Pancreatic Adenocarcinoma Panel Members